Archived Cytogenetic Cell Pellets Used to Detect a BCR::ABL1 Driver Mutation Eight Years before Disease Presentation
Evidence suggests that the earliest genetic events in the evolution of a cancer can predate diagnosis by several years or decades. In chronic myeloid leukemia (CML), the BCR::ABL1 fusion driver mutation can be present for an extended period before clinical disease manifests. The time between the BCR...
Saved in:
Main Authors: | Ramakrishnan Sasi, Michelle Spruill, Peter L. Perrotta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2024/2127657 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Imatinib-resistance without BCR/ABL Point Mutation in Chronic Myeloid Leukemia
by: Aytan Shirinova
Published: (2024-03-01) -
T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapy
by: Meng-Tung Hsu, et al.
Published: (2025-01-01) -
Identification of rare atypical BCR-ABL1 transcript: A case report
by: Jayesh Saha, et al.
Published: (2023-07-01) -
Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation
by: Stephen E. Langabeer, et al.
Published: (2023-01-01) -
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias
by: Alessandro Morotti, et al.
Published: (2015-01-01)